Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer.
Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer. J Clin Oncol. 2001 Apr 01; 19(7):2084-90.
View in:
PubMed
subject areas
Adult
Aged
Aminoquinolines
Antineoplastic Agents
Female
Genotype
Glucuronosyltransferase
Humans
Indenes
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms
Pharmacogenetics
Salvage Therapy
Topoisomerase II Inhibitors
authors with profiles
Mark J. Ratain
Richard Schilsky